1st-line treatment with BR and FCR in patients with chronic lymphocytic leukamia.

Knauf, W., Abenhardt, W., Engel, E., Grugel, R., Harde, J., Jänicke, M., Marschner, N., 2014.

Oncol Res Treat 37 (suppl5)(P186), 50. doi:10.1159/000368945

Studie: TLN; Indikation: Hämoblastosen; Jahr: 2014; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com